glutathione mutations in sclc patients

glutathione mutations in sclc patients NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced synthesis | EMBO Reports RETRACTED ARTICLE: Novel prognostic biomarkers

Name: glutathione mutations in sclc patients NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced synthesis | EMBO Reports RETRACTED ARTICLE: Novel prognostic biomarkers
Brand: www.marsberger-treibhaus.de
SKU: 9434414119
Price: 25.28 USD
Availability: InStock
Rating: 4.6624 (21 reviews)

RETRACTED ARTICLE: Novel prognostic biomarkers in small cell lung cancer reveal mutational signatures, genomic mutations, and immune implications Scientific Reports The flavonoid GL V9 induces oxidative stress mediated apoptosis in small cell lung cancer by promoting STEAP3 degradation ScienceDirect Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small cell lung cancer patients Annals of Oncology The role of ERBB4 mutations in the prognosis of advanced non small cell lung cancer treated with immune checkpoint inhibitors Molecular Medicine Springer Nature Link

SKU: 9434414119 · From www.marsberger-treibhaus.de

4.7

USD25.28 USD56.28

Pay in 4 interest-free payments of $6.32 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

However, the causal relationship between gut microbiota dysbiosis and pulmonary infections could potentially be bidirectional: in immunosuppressed or chronically ill patients, microbiota dysregulation may enhance susceptibility to pneumonia by impairing mucosal immunity